Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of MFS-16 for induction and maintenance of general anesthesia in elective surgery
ChiCTR2600133636Phase 2Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2026
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of MFS-16 and ciprofol in anesthesia for elective surgery (6 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Anesthesia success rate. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
MFS-16ciprofol
03
Conditions
anesthesia for elective surgery
Beyond the preview
Go deeper on ChiCTR2600133636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133636.